Highly differentiated breast tumors show increased expression of ERs and estrogen synthesis driving liganded ER activation and genome stabilization.In moderately differentiated breast cancers, the loss of hormone receptors upregulates the expression of HER2 receptors and kinase cascade members, strengthening the unliganded activation of scarcely occurring ERs. The gene discussed is NR4A1; the disease is breast neoplasm.